Dr. Cory G. Anderson

Family Medicine
1840 S Stapley Dr, 
Mesa, AZ 
1840 S Stapley Dr, 
Mesa, AZ 

Overview

Cory Anderson is a primary care provider, practicing in Family Medicine in Mesa, Arizona.

His clinical expertise encompasses Chronic Pain, Neuralgia, Migraine, and Bronchitis.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 19 clinical trials.

Specialties

Family Medicine

Licenses

Family Medicine in AZ

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
MercyCare
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

1840 S Stapley Dr, Mesa, AZ 85204

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

19 Clinical Trials

A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
Enrollment Status: Terminated
Publish Date: March 10, 2026
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Enrollment Status: Terminated
Publish Date: March 10, 2026
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2 Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headache
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2 Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headache
Enrollment Status: Completed
Publish Date: September 04, 2024
Intervention Type: Drug
Study Drug: ABP-450
Study Phase: Phase 2
A Phase 3 Safety, Immunogenicity, and Lot-Consistency Trial of the VLP-Based Chikungunya Vaccine PXVX0317 in Healthy Adults and Adolescents
A Phase 3 Safety, Immunogenicity, and Lot-Consistency Trial of the VLP-Based Chikungunya Vaccine PXVX0317 in Healthy Adults and Adolescents
Enrollment Status: Completed
Publish Date: August 30, 2024
Intervention Type: Biological
Study Phase: Phase 3
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Osteoarthritis Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Osteoarthritis Pain
Enrollment Status: Completed
Publish Date: July 17, 2024
Intervention Type: Drug
Study Drug: LY3526318
Study Phase: Phase 2
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
Enrollment Status: Completed
Publish Date: June 28, 2024
Intervention Type: Drug
Study Drugs: Galcanezumab, Rimegepant
Study Phase: Phase 4
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared With Placebo in Participants With Knee Osteoarthritis Pain
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared With Placebo in Participants With Knee Osteoarthritis Pain
Enrollment Status: Active_not_recruiting
Publish Date: April 08, 2024
Intervention Type: Drug
Study Drug: Pentosan Polysulfate Sodium
Study Phase: Phase 2/Phase 3
A Phase 3, Randomized, Double-blind, Parallel-group Trial to Evaluate the Lot Consistency, Immunogenicity, and Safety of AV7909 for Postexposure Prophylaxis of Anthrax in Healthy Adults
A Phase 3, Randomized, Double-blind, Parallel-group Trial to Evaluate the Lot Consistency, Immunogenicity, and Safety of AV7909 for Postexposure Prophylaxis of Anthrax in Healthy Adults
Enrollment Status: Completed
Publish Date: March 18, 2024
Intervention Type: Biological
Study Phase: Phase 3
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Biological, Other
Study Drug: SARS-CoV-2 rS/Matrix-M1 Adjuvant
Study Phase: Phase 3
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Chronic Low Back Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Chronic Low Back Pain
Enrollment Status: Completed
Publish Date: November 30, 2023
Intervention Type: Drug
Study Drug: LY3016859
Study Phase: Phase 2
View 9 Less Clinical Trials

1 Total Publications

Identification of potent CNS-penetrant thiazolidinones as novel CGRP receptor antagonists.
Identification of potent CNS-penetrant thiazolidinones as novel CGRP receptor antagonists.
Journal: Bioorganic & medicinal chemistry letters
Published: November 12, 2013
Similar Doctors
Expertise in
98
conditions
Dr. Pete S. Coury
Family Medicine
Expertise in
98
conditions
Dr. Pete S. Coury
Family Medicine

Pete Coury MD PLLC

5424 E Southern Ave, Ste 101, 
Mesa, AZ 
 (5.6 miles away)
480-654-6200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Pete Coury is a primary care provider, practicing in Family Medicine in Mesa, Arizona. Dr. Coury is highly rated in 98 conditions, according to our data. His clinical expertise encompasses Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Cirrhosis. Dr. Coury is board certified in Family Medicine. Dr. Coury is currently accepting new patients.

Expertise in
56
conditions
Dr. Merle C. Turner
Family Medicine
Expertise in
56
conditions
Dr. Merle C. Turner
Family Medicine

Warner Family Practice

2905 W Warner Rd, Ste 12, 
Chandler, AZ 
 (5.8 miles away)
480-831-8457
Languages Spoken:
English
See accepted insurances

Merle Turner is a primary care provider, practicing in Family Medicine in Chandler, Arizona. Dr. Turner is highly rated in 56 conditions, according to our data. His clinical expertise encompasses Xanthoma, Familial Combined Hyperlipidemia, Cirrhosis, and High Cholesterol. Dr. Turner is board certified in American Os Bd Family Medicine/OMT.

Expertise in
142
conditions
Dr. Elise Donnelly
Family Medicine
Expertise in
142
conditions
Dr. Elise Donnelly
Family Medicine

Honorhealh Medical Group TPK

20745 N Scottsdale Rd Ste 100, 
Scottsdale, AZ 
 (21.3 miles away)
480-882-7500
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Elise Donnelly is a primary care provider, practicing in Family Medicine in Scottsdale, Arizona. Dr. Donnelly is highly rated in 142 conditions, according to our data. Her clinical expertise encompasses Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and High Cholesterol.

Frequently Asked Questions about Dr. Cory G. Anderson

How do I make an appointment with Dr. Cory G. Anderson?

You can book an appointment with Dr. Cory G. Anderson by calling their office at 480-464-8500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Cory G. Anderson a top-rated expert for Chronic Pain?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Cory G. Anderson is classified as an Experienced expert for Chronic Pain, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Cory G. Anderson specialize in?

While Dr. Cory G. Anderson is a Family Medicine, they have specific expertise in Chronic Pain, Neuralgia, and Migraine. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Cory G. Anderson participate in research or clinical trials?

Yes. Dr. Cory G. Anderson has published 1 articles and abstracts on conditions like Chronic Pain. You can view a list of Dr. Cory G. Anderson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Cory G. Anderson accept my insurance?

Dr. Cory G. Anderson accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 480-464-8500 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Anderson's expertise for a condition
ConditionClose
        View All 10 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile